2017
DOI: 10.1126/sciadv.1701016
|View full text |Cite
|
Sign up to set email alerts
|

Ligand binding to a G protein–coupled receptor captured in a mass spectrometer

Abstract: Drug binding to the P2Y1 receptor prevents phosphorylation and competes with an endogenous ligand.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
64
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
6
2
1

Relationship

1
8

Authors

Journals

citations
Cited by 55 publications
(67 citation statements)
references
References 42 publications
1
64
0
Order By: Relevance
“…Having established the utility of OGDs for membrane protein research and native MS, we focus on one of the most challenging protein families in structural biology: GPCRs. A recent breakthrough came with the demonstration that native MS has the potential to elucidate how post-translational modifications and lipid interactions affect the structure and function of GPCRs 42,43 . However, research on GPCRs remains generally challenging, partly because of the limited range of detergents that facilitate their purification and analysis [44][45][46] .…”
Section: Resultsmentioning
confidence: 99%
“…Having established the utility of OGDs for membrane protein research and native MS, we focus on one of the most challenging protein families in structural biology: GPCRs. A recent breakthrough came with the demonstration that native MS has the potential to elucidate how post-translational modifications and lipid interactions affect the structure and function of GPCRs 42,43 . However, research on GPCRs remains generally challenging, partly because of the limited range of detergents that facilitate their purification and analysis [44][45][46] .…”
Section: Resultsmentioning
confidence: 99%
“…To this end, mass spectrometry (MS) has enabled the discovery of several bioactive peptides (Fricker et al, ; Hatcher et al, ), even though it is very difficult to detect the inherently limited temporal and spatial expression of secreted peptides in mixed samples containing large quantities of other proteins. MS has been applied to peptide ligand screening, as it is label‐free and unbiased with respect to signalling pathways (Yen et al, ). Recently, HPLC and MS of bile and cell culture supernatants have led to the discovery of a post‐translationally modified peptide, S‐geranylgeranyl‐L‐GSH as a potent endogenous ligand for the orphan receptor P2RY8 (Lu, Wolfreys, Muppidi, Xu, & Cyster, ).…”
Section: Approaches For Peptide‐gpcr De‐orphanisationmentioning
confidence: 99%
“…To this end, mass spectrometry (MS) has enabled the discovery of several bioactive peptides (Fricker et al, 2000;Hatcher et al, 2008), even though it is very difficult to detect the inherently limited temporal and spatial expression of secreted peptides in mixed samples containing large quantities of other proteins. MS has been applied to peptide ligand screening, as it is label-free and unbiased with respect to signalling pathways (Yen et al, 2017).…”
mentioning
confidence: 99%
“…Studies of the ABC transporter P-gp [27] revealed that this protein preferentially binds to negatively charged lipids and cardiolipins (over zwitterionic lipids), and that binding to an inhibitor enhances cardiolipin binding, demonstrating that native MS could be used to probe synergistic binding events. Native MS has also been used to capture off-target drug interactions with MPs [131] and, excitingly, to monitor ligand binding to G-protein-coupled receptors (GPCRs), enabling native MS methods to be applied to GPCR drug discovery [132].…”
Section: Stoichiometry Ligand and Lipid Binding And Thermodynamics Rmentioning
confidence: 99%